
Baxter BioPharma Solutions
Advertisement
Articles by Baxter BioPharma Solutions


Your oncology product can make a difference in patients’ lives, and our oncology manufacturing expertise can help you make that difference.


- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation

This case study looks at considerations for formulations of Mannitol, a versatile excipient used in freeze-dried injectables in the pharmaceutical industry.
Advertisement
Latest Updated Articles
Complex Sterile Manufacturing of Oncology ProductsPublished: October 20th 2020 | Updated:
Hemihydrate Formation: Considerations for Mannitol FormulationsPublished: February 24th 2020 | Updated:
Oncology Product Manufacturing in a Non-Dedicated FacilityPublished: March 19th 2020 | Updated:
Oncology Product Manufacturing in a Nondedicated FacilityPublished: March 19th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Audits, Inspections, and CDMOs
3
Ready or Not: Biopharma Alignment for CNPV’s Rapid Review
4
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
5
